These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38718670)

  • 1. Electronic health records and e-prescribing in Australia: An exploration of technological utilisation in Australian community pharmacies.
    Hareem A; Stupans I; Park JS; Stevens JE; Wang K
    Int J Med Inform; 2024 Jul; 187():105472. PubMed ID: 38718670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality and Variability of Patient Directions in Electronic Prescriptions in the Ambulatory Care Setting.
    Yang Y; Ward-Charlerie S; Dhavle AA; Rupp MT; Green J
    J Manag Care Spec Pharm; 2018 Jul; 24(7):691-699. PubMed ID: 29345553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impacts of second generation e-prescribing usability on community pharmacists outcomes.
    Peikari HR; Shah MH; Zakaria MS; Yasin NM; Elhissi A
    Res Social Adm Pharm; 2015; 11(3):339-51. PubMed ID: 25262599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A national survey exploring oral healthcare service provision across Australian community pharmacies.
    Freeman CR; Abdullah N; Ford PJ; Taing MW
    BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of pharmacists' interventions on electronic versus traditional prescriptions in 2 community pharmacies.
    Gilligan AM; Miller K; Mohney A; Montenegro C; Schwarz J; Warholak TL
    Res Social Adm Pharm; 2012; 8(6):523-32. PubMed ID: 22264963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the frequency of dispensing electronically discontinued medications and associated outcomes.
    Copi EJ; Kelley LR; Fisher KK
    J Am Pharm Assoc (2003); 2018; 58(4S):S46-S50. PubMed ID: 29752205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of pharmacy practice on community pharmacists' integration of medication and lab value information from electronic health records.
    Hughes CA; Guirguis LM; Wong T; Ng K; Ing L; Fisher K
    J Am Pharm Assoc (2003); 2011; 51(5):591-8. PubMed ID: 21896456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of community chain pharmacists' interventions on electronic prescriptions.
    Warholak TL; Rupp MT
    J Am Pharm Assoc (2003); 2009; 49(1):59-64. PubMed ID: 19196598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The introduction of the national e-health record into Australian community pharmacy practice: pharmacists' perceptions.
    Mooranian A; Emmerton L; Hattingh L
    Int J Pharm Pract; 2013 Dec; 21(6):405-12. PubMed ID: 23560554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between e-prescriptions and community pharmacy workflow.
    Odukoya OK; Chui MA
    J Am Pharm Assoc (2003); 2012; 52(6):e168-74. PubMed ID: 23229979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and barriers associated with e-prescribing in community pharmacy - A systematic review.
    Hareem A; Lee J; Stupans I; Park JS; Wang K
    Explor Res Clin Soc Pharm; 2023 Dec; 12():100375. PubMed ID: 38145236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community pharmacists' lack of access to health records and its impact on targeted MTM interventions.
    Roberts MF; Reeves K; Divine H
    J Am Pharm Assoc (2003); 2019; 59(4S):S81-S84. PubMed ID: 31203016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-prescribing errors identified in a compounding pharmacy: a quality-improvement project.
    Reed-Kane D; Kittell K; Adkins J; Flocks S; Nguyen T
    Int J Pharm Compd; 2014; 18(1):83-6. PubMed ID: 24881345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges to the implementation of a nationwide electronic prescribing network in primary care: a qualitative study of users' perceptions.
    Motulsky A; Sicotte C; Gagnon MP; Payne-Gagnon J; Langué-Dubé JA; Rochefort CM; Tamblyn R
    J Am Med Inform Assoc; 2015 Jul; 22(4):838-48. PubMed ID: 25882033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmitting and processing electronic prescriptions: experiences of physician practices and pharmacies.
    Grossman JM; Cross DA; Boukus ER; Cohen GR
    J Am Med Inform Assoc; 2012; 19(3):353-9. PubMed ID: 22101907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Preliminary Scoping Review of the Impact of e-Prescribing on Pharmacists in Community Pharmacies.
    Farghali AA; Borycki EM
    Healthcare (Basel); 2024 Jun; 12(13):. PubMed ID: 38998815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded prescribing: a comparison of the views of Australian hospital and community pharmacists.
    Hoti K; Hughes J; Sunderland B
    Int J Clin Pharm; 2013 Jun; 35(3):469-75. PubMed ID: 23549776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and challenges of electronic prescribing for general practitioners and pharmacists in regional Australia.
    Tan T; Chan S; Ind M; Pace G; Bailey J; Reed K; Dutton T; Osuagwu UL; Wong KC
    Aust J Rural Health; 2023 Aug; 31(4):776-781. PubMed ID: 37243842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community pharmacists' attitudes and opinions towards supplying clozapine.
    Gan YL; O'Reilly CL
    Int J Clin Pharm; 2018 Oct; 40(5):1116-1130. PubMed ID: 29936642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.